Point72 Hong Kong LTD Oncorus, Inc. Transaction History

Point72 Hong Kong LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.04 - $1.86 $1,407 - $2,516	-1,353 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.44 - $5.62 $1,709 - $6,670	1,187 Added 715.06%	1,353 $2,000
Q4 2021 Feb 14, 2022	BUY	$5.03 - $11.63 $834 - $1,930	166 New	166 $1,000
Q1 2021 May 17, 2021	SELL	$11.89 - $35.55 $14,303 - $42,766	-1,203 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$15.0 - $35.15 $18,045 - $42,285	1,203 New	1,203 $39,000

Ticker ONCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,973,100
Description
Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various canc...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.